FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Kamijo, K; Murayama, H; Uzu, T et al.
A Novel Bioreporter Assay for Thyrotropin Receptor Antibodies Using a Chimeric Thyrotropin Receptor (Mc4) Is More Useful in Differentiation of Graves' Disease from Painless Thyroiditis Than Conventional Thyrotropin-Stimulating Antibody Assay Using Porcine Thyroid CellsTHYROID. Bd. 20. H. 8. 2010 S. 851-856
Bockamp, E; Abassi, Y; Robine, S et al.
A novel conditional mouse model for studying intestinal cancerNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 381. 2010 S. 84-84
Okuyama, M; Kayama, H; Atarashi, K et al.
A novel in vivo inducible dendritic cell ablation model in miceBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Bd. 397. H. 3. 2010 S. 559-563
Cluny, NL; Vemuri, VK; Chambers, AP et al.
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodentsBRITISH JOURNAL OF PHARMACOLOGY. Bd. 161. H. 3. 2010 S. 629-642
Tomicic, MT; Reichmann, P; Rasenberger, B et al.
A novel role for c-Fos/AP-1 in the regulation of XPF endonuclease in UV-irradiated human fibroblastsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 381. 2010 S. 72-72
Lytton, SD; Ponto, KA; Kanitz, M et al.
A Novel Thyroid Stimulating Immunoglobulin Bioassay Is a Functional Indicator of Activity and Severity of Graves' OrbitopathyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 95. H. 5. 2010 S. 2123-2131
Daubner, T; Fink, A; Seitz, A et al.
A novel transmembrane domain mediating retention of a highly motile herpesvirus glycoprotein in the endoplasmic reticulumJOURNAL OF GENERAL VIROLOGY. Bd. 91. 2010 S. 1524-1534
Kaechele, V; Moehler, M; Lutz, MP et al.
A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische OnkologieCANCER CHEMOTHERAPY AND PHARMACOLOGY. Bd. 66. H. 1. 2010 S. 191-195
Cornely, OA; Vehreschild, JJ; Ruping, MJGT et al.
A phase II dose escalation study of caspofungin for invasive aspergillosisMYCOSES. Bd. 53. H. 5. 2010 S. 376-377
Weidmann, E; Hess, G; Chow, KU et al.
A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomasLEUKEMIA & LYMPHOMA. Bd. 51. H. 3. 2010 S. 447-455